Clinical Trials · NCT01572740
Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 257
- Start date
- Apr 2012
- Locations
- 23 sites, Japan
- Primary endpoint
- Change in Glycosylated Haemoglobin (HbA1c) From Baseline to Week 16